Prof. B.J. Biemond PhD publications

2021

• Hamulyak Eva N., Daams Joost G., Leebeek Frank W. G., Biemond Bart J., te Boekhorst Peter A. W., Middeldorp Saskia, Lauw Mandy N. A systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasms Blood advances 2021;5 (1):113-121
• Janssen Jeroen, Löwenberg Bob, Manz Markus, Bargetzi Mario, Biemond Bart, von dem Borne Peter, Breems Dimitri, Brouwer Rolf, Chalandon Yves, Deeren Dries, Efthymiou Anna, Gjertsen Bjørn-Tore, Graux Carlos, Gregor Michael, Heim Dominik, Hess Urs, Hoogendoorn Mels, Jaspers Aurelie, Jie Asiong, Jongen-Lavrencic Mojca, Klein Saskia, van der Klift Marjolein, Kuball J. rgen, van Lammeren-Venema Danielle, Legdeur Marie-Cecile, van de Loosdrecht Arjan, Maertens Johan, Kooy Marinus van Marwijk, Moors Ine, Nijziel Marten, van Obbergh Florence, Oosterveld Margriet, Pabst Thomas, van der Poel Marjolein, Sinnige Harm, Spertini Olivier, Terpstra Wim, Tick Lidwine, van der Velden Walter, Vekemans Marie-Christiane, Vellenga Edo, de Weerdt Okke, Westerweel Peter, Stüssi Georg, van Norden Yvette, Ossenkoppele Gert Inferior outcome of addition of the aminopeptidase inhibitor tosedostat to standard intensive treatment for elderly patients with aml and high risk mds Cancers 2021;13 (4):1-11 [PubMed]

2020

• de Mooij Charlotte E. M., van Groningen Lenneke F. J., de Haan Anton F. J., Biemond Bart J., Bakker Martijn, van der Velden Walter J. F. M., Blijlevens Nicole M. A. Anakinra: efficacy in the management of fever during neutropenia and mucositis in autologous stem cell transplantation (AFFECT-2)—study protocol for a multicenter randomized double-blind placebo-controlled trial Trials 2020;21 (1) [PubMed]
• van Baarle Frank E. H. P., van de Weerdt Emma K., Suurmond Bram, Müller Marcella C. A., Vlaar Alexander P. J., Biemond Bart J. Bleeding assessment and bleeding severity in thrombocytopenic patients undergoing invasive procedures Transfusion 2020;60 (3):637-649 [PubMed]
• Ossenkoppele G. J., Breems D. A., Stuessi G., van Norden Y., Bargetzi M., Biemond B. J., A von dem Borne P., Chalandon Y., Cloos J., Deeren D., Fehr M., Gjertsen B., Graux C., Huls G., Janssen J. J. J. W., Jaspers A., Jongen-Lavrencic M., de Jongh E., Klein S. K., van der Klift M., van Marwijk Kooy M., Maertens J., Michaux L., van der Poel M. W. M., van Rhenen A., Tick L., Valk P., Vekemans M. C., van der Velden W. J. F. M., de Weerdt O., Pabst T., Manz M., Löwenberg B., Breems D. A., Vekemans M. C., Moors I., van Obberg F., Maertens J. A., Hodossy B., Vansteenweghen S., Lammertijn L., Deeren D., Graux C., Sonet A., Triffet A., Gjertsen B. T., Bargetzi M., Passweg J., Biemond B. J. Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS (Leukemia, (2020), 34, 7, (1751-1759), 10.1038/s41375-020-0725-0) Leukemia 2020;34 (10):2820 [PubMed]
• Tang Man Wai, Nur Erfan, Biemond Bart J. Immune Thrombocytopenia during Pregnancy due to COVID-19 American journal of hematology 2020 [PubMed]
• van Tuijn Charlotte F. J., Gaartman Aafke E., Nur Erfan, Rijneveld Anita W., Biemond Bart J. Incentive spirometry to prevent acute chest syndrome in adults with sickle cell disease; a randomized controlled trial American journal of hematology 2020;95 (7):E160-E163 [PubMed]
• Ossenkoppele G. J., Breems D. A., Stuessi G., van Norden Y., Bargetzi M., Biemond B. J., A von dem Borne P., Chalandon Y., Cloos J., Deeren D., Fehr M., Gjertsen B., Graux C., Huls G., Janssen J. J. J. W., Jaspers A., Jongen-Lavrencic M., de Jongh E., Klein S. K., van der Klift M., van Marwijk Kooy M., Maertens J., Micheaux L., van der Poel M. W. M., van Rhenen A., Tick L., Valk P., Vekemans M. C., van der Velden W. J. F. M., de Weerdt O., Pabst T., Manz M., Löwenberg B., Breems D. A., Vekemans M. C., Moors I., van Obberg F., Maertens J. A., Hodossy B., Vansteenweghen S., Lammertijn L., Deeren D., Graux C., Sonet A., Triffet A., Gjertsen B. T., Bargetzi M., Biemond B. J., Biemond B. J. Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS Leukemia 2020;34 (7):1751-1759 [PubMed]
• Hansen Dennis Lund, Glenthøj Andreas, Möller S. ren, Biemond Bart J., Andersen Kjeld, Gaist David, Petersen Jesper, Frederiksen Henrik Prevalence of congenital hemolytic disorders in Denmark, 2000–2016 Clinical epidemiology 2020;12:485-495 [PubMed]
• Zhao Moss Y., Václavů Lena, Petersen Esben T., Biemond Bart J., Sokolska Magdalena J., Suzuki Yuriko, Thomas David L., Nederveen Aart J., Chappell Michael A. Quantification of cerebral perfusion and cerebrovascular reserve using Turbo-QUASAR arterial spin labeling MRI Magnetic resonance in medicine 2020;83 (2):731-748 [PubMed]
• Nur E., Gaartman A. E., van Tuijn C. F. J., Tang M. W., Biemond B. J. Vaso-occlusive Crisis and Acute Chest Syndrome in Sickle Cell Disease due to 2019 Novel Coronavirus Disease (COVID-19) American journal of hematology 2020;95 (6):725-726 [PubMed]

2019

• Huls Gerwin, Chitu Dana A., Havelange Violaine, Jongen-Lavrencic Mojca, van de Loosdrecht Arjan A., Biemond Bart J., Sinnige Harm, Hodossy Beata, Graux Carlos, Kooy Rien van Marwijk, de Weerdt Okke, Breems Dimitri, Klein Saskia, Kuball J. rgen, Deeren Dries, Terpstra Wim, Vekemans Marie-Christiane, Ossenkoppele Gert J., Vellenga Edo, Löwenberg Bob Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients Blood 2019;133 (13):1457-1464 [PubMed]
• de Bruin Sanne, van de Weerdt Emma K., Sijbrands Davina, Vlaar Richard, Gouwerok Eric, Biemond Bart J., Vlaar Alexander P. J., van Bruggen Robin, de Korte Dirk Biotinylation of platelets for transfusion purposes a novel method to label platelets in a closed system Transfusion 2019;59 (9):2964-2973 [PubMed]
• Václavů Lena, Petr Jan, Petersen Esben Thade, Mutsaerts Henri J. M. M., Majoie Charles B. L., Wood John C., VanBavel Ed, Nederveen Aart J., Biemond Bart J. Cerebral oxygen metabolism in adults with sickle cell disease American journal of hematology 2019 [PubMed]
• Václavů Lena Haemodynamic MRI in sickle cell disease 2019. 153p. ISBN 9789463236799. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Nederveen A. J. , van Bavel E. T.; Co-supervisors: Biemond B. J. , Majoie Ch. B. L. M.)
• Václavů Lena, Meynart Benoit N., Mutsaerts Henri J. M. M., Petersen Esben Thade, Majoie Charles B. L. M., VanBavel Ed T., Wood John C., Nederveen Aart J., Biemond Bart J. Hemodynamic provocation with acetazolamide shows impaired cerebrovascular reserve in adults with sickle cell disease Haematologica 2019;104 (4):690-699 [PubMed]
• Meinderts Sanne M, Gerritsma Jorn J, Sins Joep W R, de Boer Martin, van Leeuwen Karin, Biemond Bart J, Rijneveld Anita W, Kerkhoffs Jean-Louis H, Habibi Anoosha, van Bruggen Robin, Kuijpers Taco W, van der Schoot Ellen, Pirenne France, Fijnvandraat Karin, Tanck Michael W, van den Berg Timo K Identification of genetic biomarkers for alloimmunization in sickle cell disease British journal of haematology 2019;186 (6):887-899 [PubMed]
• van Raaij Sanne E. G., Rennings Alexander J., Biemond Bart J., Schols Saskia E. M., Wiegerinck Erwin T. G., Roelofs Hennie M. J., Hoorn Ewout J., Walsh Stephen B., Nijenhuis Tom, Swinkels Dorine W., van Swelm Rachel P. L. Iron handling by the human kidney: glomerular filtration and tubular reabsorption both contribute to urinary iron excretion American journal of physiology. Renal physiology 2019;316 (3):F606-F614 [PubMed]
• de Vries Vera A., Müller Marcella C. A., Arbous M. Sesmu, Biemond Bart J., Blijlevens Nicole M. A., Kusadasi Nuray, Span Lambert R. F., Vlaar Alexander P. J., van Westerloo David J., Kluin-Nelemans Hanneke C., van den Bergh Walter M. Long-Term Outcome of Patients With a Hematologic Malignancy and Multiple Organ Failure Admitted at the Intensive Care Critical care medicine 2019;47 (2):e120-e128 [PubMed]
• van de Weerdt Emma K. Platelet transfusion in patients undergoing minor invasive procedures: Balancing risks and benefits 2019. 221p. ISBN 9789463752596. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Biemond B. B.; Co-supervisor: Vlaar A. P. J.)
• van der Heiden P. L. J., Arbous M. S., van Beers E. J., van den Bergh W. M., le Cessie S., Demandt A. M. P., Eefting M., Hess C., Kusadasi N., Marijt W. A. F., van Mook W. N. K. A., Müller M. C. A., Tuinman P. R., van Vliet M., van Westerloo D. J., Blijlevens N. M. A., Biemond Bart J., Müller Marcella C. A., Vlaar Alexander J., Tuinman Pieter R., Spoelstra Angelique M., Arbous M. Sesmu, van Westerloo David J., van der Heiden Pim L. J., van Vliet Maarten, Blijlevens Nicole M. A., Hilkens Murielle, van den Bergh Walter M., Kluin Hanneke C., van Mook Walther N. K. A., Demandt Astrid M. P., Kusadasi Nuray, Biemond Bart J., Müller Marcella C. A., Vlaar Alexander J., Tuinman Pieter R., Spoelstra Angelique M., Arbous M. Sesmu, van Westerloo David J., van der Heiden Pim L. J., van Vliet Maarten, Blijlevens Nicole M. A., Hilkens Murielle, van den Bergh Walter M., Kluin Hanneke C., van Mook Walther N. K. A., Demandt Astrid M. P., Kusadasi Nuray Predictors of short-term and long-term mortality in critically ill patients admitted to the intensive care unit following allogeneic stem cell transplantation Bone marrow transplantation 2019;54 (3):418-424 [PubMed]
• Houwing M. E., de Pagter P. J., van Beers E. J., Biemond B. J., Rettenbacher E., Rijneveld A. W., Schols E. M., Philipsen J. N. J., Tamminga R. Y. J., van Draat K. Fijn, Nur E., Cnossen M. H., Study group members AMC , Heijboer Harriet Sickle cell disease: Clinical presentation and management of a global health challenge Blood reviews 2019;37 (September) [PubMed]
• de Jong Greta, Janssen Jeroen J. W. M., Biemond Bart J., Zeerleder Sacha S., Ossenkoppele Gert J., Visser Otto, Nur Erfan, Meijer Ellen, Hazenberg Mette D. Survival of early posthematopoietic stem cell transplantation relapse of myeloid malignancies European journal of haematology 2019;103 (5):491-499 [PubMed]
• Schuster Stephen J., Bishop Michael R., Tam Constantine S., Waller Edmund K., Borchmann Peter, McGuirk Joseph P., Jäger Ulrich, Jaglowski Samantha, Andreadis Charalambos, Westin Jason R., Fleury Isabelle, Bachanova Veronika, Foley S. Ronan, Ho P. Joy, Mielke Stephan, Magenau John M., Holte Harald, Pantano Serafino, Pacaud Lida B., Awasthi Rakesh, Chu Jufen, Anak Özlem, Salles Gilles, Maziarz Richard T., Study group members AMC , Kersten Marie José J., Biemond Bart J., Burger Patrick, Claessen Marie-José J. A. G., Hazenberg Mette D., Kater Arnon P., Kemper E. M., Nur Erfan, Spiering Marjolein, Tonino Sanne H., Voermans Carlijn, Zeerleder Sacha S. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma New England journal of medicine 2019;380 (1):45-56 [PubMed]
• Nur E. , van Beers E. J., Biemond B. J. Uw diagnose? Nederlands tijdschrift voor hematologie 2019;16 (7):368-369

2018

• Vlijm-Kievit Anniek, Jorna Nori G. E., Moll Etelka, Pajkrt Eva, Pals Steven T., Middeldorp Saskia, Biemond Bart J., Zeerleder Sacha S., Tio Marieke A., Kemper E. Marleen, Hazenberg Mette D. Acute lymphoblastic leukemia during the third trimester of pregnancy Leukemia & lymphoma 2018;59 (5):1274-1276 [PubMed]
• Sins Joep W. R., Fijnvandraat Karin, Rijneveld Anita W., Boom Martine B., Kerkhoffs Jean-Louis H., van Meurs Alfred H., de Groot Marco R., Heijboer Harriët, Dresse Marie-Françoise, Lê Phu Quoc, Hermans Philippe, Vanderfaeillie Anna, van den Neste Eric W., Benghiat Fleur S., Kesse-Adu Rachel, Delannoy André, Efira André, Azerad Marie-Agnès, de Borgie Corianne A., Biemond Bart J. Effect of N-acetylcysteine on pain in daily life in patients with sickle cell disease: a randomised clinical trial British journal of haematology 2018;182 (3):444-448 [PubMed]
• Václavů Lena, Baldew Zelonna A. V., Gevers Sanna, Mutsaerts Henri J. M. M., Fijnvandraat Karin, Cnossen Marjon H., Majoie Charles B., Wood John C., VanBavel Ed, Biemond Bart J., van Ooij Pim, Nederveen Aart J. Intracranial 4D flow magnetic resonance imaging reveals altered haemodynamics in sickle cell disease British journal of haematology 2018;180 (3):432-442 [PubMed]
• van Straaten Stephanie, Biemond Bart J., Kerkhoffs Jean-Louis, Gitz-Francois Jerney, van Wijk Richard, van Beers Eduard J. Iron overload in patients with rare hereditary hemolytic anemia: Evidence-based suggestion on whom and how to screen American journal of hematology 2018;93 (11):E374-E376 [PubMed]
• Jongen-Lavrencic M., Grob T., Hanekamp D., Kavelaars F. G., Al Hinai A., Zeilemaker A., Erpelinck-Verschueren C. A. J., Gradowska P. L., Meijer R., Cloos J., Biemond B. J., Graux C., van Marwijk Kooy M., Manz M. G., Pabst T., Passweg J. R., Havelange V., Ossenkoppele G. J., Sanders M. A., Schuurhuis G. J., Lowenberg B., Valk P. J. M. Molecular minimal residual disease in acute myeloid leukemia New England journal of medicine 2018;378 (13):1189-1199 [PubMed]
• van de Weerdt Emma K., Biemond Bart J., Zeerleder Sacha S., van Lienden Krijn P., Binnekade Jan M., Vlaar Alexander P. J., van Leent A., Koeman M., Ypma P. F., Arbous M. S., Demandt A. M. P., van Mook W. N. K. A., Tordoir J. H. M., Wolthuis E., Blomjous J. G. A. M., Determann R. M., Endeman H., Kerver E. D., van der Velden W. J. F. M., Vink R., Bokkers R. P. H., Mäkelburg A. B. U., van den Bergh W. M., Tuinman P. R., van Leent A., Koeman M., Ypma P. F., Arbous M. S., Demandt A. M. P., van Mook W. N. K. A., Tordoir J. H. M., Wolthuis E., Blomjous J. G. A. M., Determann R. M., Endeman H., Kerver E. D., van der Velden W. J. F. M., Vink R., Bokkers R. P. H., Mäkelburg A. B. U., van den Bergh W. M., Tuinman P. R. Prophylactic platelet transfusion prior to central venous catheter placement in patients with thrombocytopenia: Study protocol for a randomised controlled trial Trials 2018;19 (1) [PubMed]
• van Tuijn Charlotte F. J. Sickle cell disease: Evaluation and management of disease burden 2018. ISBN 9789463610940. [UvA Dissertations Online] University of Amsterdam. (Supervisor: van Oers M. H. J.; Co-supervisor: Biemond B. J.)
• Schauwvlieghe Alexander F. A. D., de Jonge Nick, van Dijk Karin, Verweij Paul E., Brüggemann Roger J., Biemond Bart J., Bart Aldert, von dem Borne Peter A., Verbon Annelies, van der Beek Martha T., Demandt Astrid M. P., Oudhuis Guy J., Cornelissen Jan J., van der Velden Walter J. F. M., Span Lambert F. R., Kampinga Greetje A., Bruns Anke H., Vonk Alieke G., Haas Pieter–Jan A., Doorduijn Jeanette K., Rijnders Bart J. A. The diagnosis and treatment of invasive aspergillosis in Dutch haematology units facing a rapidly increasing prevalence of azole-resistance. A nationwide survey and rationale for the DB-MSG 002 study protocol Mycoses 2018;61 (9):656-664 [PubMed]
• de Vries Vera A., Müller Marcella C. A., Sesmu Arbous M., Biemond Bart J., Blijlevens Nicole M. A., Kusadasi Nuray, Choi Goda C. W., Vlaar Alexander P. J., van Westerloo David J., Kluin-Nelemans Hanneke C., van den Bergh Walter M., Tuinman Pieter Roel, Spoelstra Angelique, Wondergem Marielle, Arbous Sesmu, Westerloo David V., Marijt Erik, Blijlevens Nicole, Jobse Pieter, Hilkens Murielle, Epker Jelle, Broers Annoek, Kluin-Nelemans Hanneke, Choi Goda, de Vries Vera, Demandt Astrid, van Mook Walther, Bruns Anke Time trend analysis of long term outcome of patients with haematological malignancies admitted at dutch intensive care units British journal of haematology 2018;181 (1):68-76 [PubMed]

2017

• van de Weerdt Emma K., Biemond Bart J., Baake Bart, Vermin Ben, Binnekade Jan M., van Lienden Krijn P., Vlaar Alexander P. J. Central venous catheter placement in coagulopathic patients: risk factors and incidence of bleeding complications Transfusion 2017;57 (10):2512-2525 [PubMed]
• Versluis J., In 't Hout F. E. M., Devillier R., van Putten W. L. J., Manz M. G., Vekemans M.-C., Legdeur M.-C., Passweg J. R., Maertens J., Kuball J., Biemond B. J., Valk P. J. M., van der Reijden B. A., Meloni G., Schouten H. C., Vellenga E., Pabst T., Willemze R., Löwenberg B., Ossenkoppele G., Baron F., Huls G., Cornelissen J. J. Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio Leukemia 2017;31 (1):26-33 [PubMed]
• van Tuijn Charlotte F. J., Sins Joep W. R., Fijnvandraat Karin, Biemond Bart J. Daily pain in adults with sickle cell disease-a different perspective American journal of hematology 2017;92 (2):179-186 [PubMed]
• Sins J. W. R., Schimmel M., Luken B. M., Nur E., Zeerleder S. S., van Tuijn C. F. J., Brandjes D. P. M., Kopatz W. F., Urbanus R. T., Meijers J. C. M., Biemond B. J., Fijnvandraat K. Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady state Journal of thrombosis and haemostasis 2017;15 (7):1392-1402 [PubMed]
• Schimmel Marein, Luken Brenda M., Nur Erfan, van Tuijn Charlotte F. J., Sins Joep W., Brandjes Dees P. M., Zeerleder Sacha S., Biemond Bart J. Inflammatory and endothelial markers during vaso-occlusive crisis and acute chest syndrome in sickle cell disease American journal of hematology 2017;92 (11):E634-E636 [PubMed]
• Meinderts Sanne M., Sins Joep W. R., Fijnvandraat Karin, Nagelkerke Sietse Q., Geissler Judy, Tanck Michael W., Bruggeman Christine, Biemond Bart J., Rijneveld Anita W., Kerkhoffs Jean-Louis H., Pakdaman Sadaf, Habibi Anoosha, van Bruggen Robin, Kuijpers Taco W., Pirenne France, van den Berg Timo K. Nonclassical FCGR2C haplotype is associated with protection from red blood cell alloimmunization in sickle cell disease Blood 2017;130 (19):2121-2130 [PubMed]
• Sins Joep W. R., Mager David J., Davis Shyrin C. A. T., Biemond Bart J., Fijnvandraat Karin Pharmacotherapeutical strategies in the prevention of acute, vaso-occlusive pain in sickle cell disease: a systematic review Blood advances 2017;1 (19):1598-1616 [PubMed]
• van Tuijn Charlotte F. J., Schimmel Marein, van Beers Eduard J., Nur Erfan, Biemond Bart J. Prospective evaluation of chronic organ damage in adult sickle cell patients: A seven-year follow-up study American journal of hematology 2017;92 (10):E584-E590 [PubMed]
• Schimmel Marein Sickle cell disease: Pathogenesis and biomarkers 2017. 205p. ISBN 9789492683441. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Brandjes D. P. M. , van Oers M. H. J.; Co-supervisors: Biemond B. J. , Zeerleder S. S.)
• van de Weerdt E. K., Peters A. L., Goudswaard E. J., Binnekade J. M., van Lienden K. P., Biemond B. J., Vlaar A. P. J. The practice of platelet transfusion prior to central venous catheterization in presence of coagulopathy: a national survey among clinicians Vox sanguinis 2017;112 (4):343-351 [PubMed]
• Sins Joep W. R. Therapeutic targets in sickle cell disease 2017. 283p. ISBN 9789492683960. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Fijnvandraat C. J., van Oers M. H. J.; Co-supervisors: Biemond B. J., Kuijpers T. W.)
• Boshuizen M., van der Ploeg K., von Bonsdorff L., Biemond B. J., Zeerleder S. S., van Bruggen R., Juffermans N. P. Therapeutic use of transferrin to modulate anemia and conditions of iron toxicity Blood reviews 2017;31 (6):400-405 [PubMed]
• Löwenberg Bob, Pabst Thomas, Maertens Johan, van Norden Yvette, Biemond Bart J., Schouten Harry C., Spertini Olivier, Vellenga Edo, Graux Carlos, Havelange Violaine, de Greef Georgine E., de Weerdt Okke, Legdeur Marie-Cecile J. C., Kuball Juergen, Kooy Marinus van Marwijk, Gjertsen Bjorn T., Jongen-Lavrencic Mojca, van de Loosdrecht Arjan A., van Lammeren-Venema Daniëlle, Hodossy Beata, Breems Dimitri A., Chalandon Yves, Passweg Jakob, Valk Peter J. M., Manz Markus G., Ossenkoppele Gert J. Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML Blood 2017;129 (12):1636-1645 [PubMed]
• Klaassen Irene L. M., Lauw Mandy N., van de Wetering Marianne D., Biemond Bart J., Middeldorp Saskia, Abbink Floor C. H., Bierings Marc, te Loo D. Maroeska M. W., Pieters Rob, van der Sluis Inge M., Tissing Wim J. E., Zwaan C. Michel, van Ommen C. Heleen TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial BMC pediatrics 2017;17 (1) [PubMed]

2016

• Slot Linda M., Hoogeboom Robbert, Smit Laura A., Wormhoudt Thera A. M., Biemond Bart J., Oud Monique E. C. M., Schilder-Tol Esther J. M., Mulder André B., Jongejan Aldo, van Kampen Antoine H. C., Kluin Philip M., Guikema Jeroen E. J., Bende Richard J., van Noesel Carel J. M. B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains American journal of pathology 2016;186 (12):3273-3284 [PubMed]
• Sins Joep W. R., Biemond Bart J., van den Bersselaar Sil M., Heijboer H., Rijneveld Anita W., Cnossen Marjon H., Kerkhoffs Jean-Louis H., van Meurs Alfred H., von Ronnen F. B., Zalpuri Saurabh, de Rijke Yolanda B., Ellen van der Schoot C., de Haas Masja, van der Bom Johanna G., Fijnvandraat Karin Early occurrence of red blood cell alloimmunization in patients with sickle cell disease American journal of hematology 2016;91 (8):763-769 [PubMed]
• de Swart Louise, Hendriks Jan C. M., van der Vorm Lisa N., Cabantchik Z. Ioav, Evans Patricia J., Hod Eldad A., Brittenham Gary M., Furman Yael, Wojczyk Boguslaw, Janssen Mirian C. H., Porter John B., Mattijssen Vera E. J. M., Biemond Bart J., MacKenzie Marius A., Origa Raffaella, Galanello Renzo, Hider Robert C., Swinkels Dorine W. Second international round robin for the quantification of serum non-transferrin-bound iron and labile plasma iron in patients with iron-overload disorders Haematologica 2016;101 (1):38-45 [PubMed]
• Biemond B. J. Selectineremming als anti-adhesieve therapie bij sikkelcelziekte Nederlands tijdschrift voor hematologie 2016;13 (7):270-274
• Schimmel M., Nur E., Mairuhu W., Brandjes D. P. M., Olde Engberink R. H. G., Vogt L., Biemond B. J. Urinary zinc loss in sickle cell disease primarily due to increased bone degradation American journal of hematology 2016;91 (6):E311-E312 [PubMed]

2015

• van der Land Veronica, Zwanenburg Jaco J. M., Fijnvandraat Karin, Biemond Bart J., Hendrikse Jeroen, Mutsaerts Henri J. M. M., Visser Fredy, Wardlaw Joanna M., Nederveen Aart J., Majoie Charles B. L. M., Nederkoorn Paul J. Cerebral lesions on 7 tesla MRI in patients with sickle cell anemia Cerebrovascular diseases (Basel, Switzerland) 2015;39 (3-4):181-189 [PubMed]
• Zuurbier Susanna M., Lauw Mandy N., Coutinho Jonathan M., Majoie Charles B. L. M., van der Holt Bronno, Cornelissen Jan J., Middeldorp Saskia, Biemond Bart J., Stam Jan Clinical Course of Cerebral Venous Thrombosis in Adult Acute Lymphoblastic Leukemia Journal of stroke and cerebrovascular diseases 2015;24 (7):1679-1684 [PubMed]
• Cornelissen J. J., Versluis J., Passweg J. R., van Putten W. L. J., Manz M. G., Maertens J., Beverloo H. B., Valk P. J. M., van Marwijk Kooy M., Wijermans P. W., Schaafsma M. R., Biemond B. J., Vekemans M.-C., Breems D. A., Verdonck L. F., Fey M. F., Jongen-Lavrencic M., Janssen J. J. W. M., Huls G., Kuball J., Pabst T., Graux C., Schouten H. C., Gratwohl A., Vellenga E., Ossenkoppele G., Löwenberg B. Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years Leukemia 2015;29 (5):1041-1050 [PubMed]
• Montgomery Michael, van Santen Marije M., Biemond Bart J., Diamond Robert H., Pals Steven T. Hepatosplenic T-Cell Lymphoma: A Population-Based Study Assessing Incidence and Association With Immune-Mediated Disease Gastroenterology & hepatology 2015;11 (3):160-163 [PubMed]
• Lauw Mandy Nicole Hypercoagulability in hematological malignancies 2015. 293p. ISBN 9789461697097. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Middeldorp S., van Oers M. H. J.; Co-supervisor: Biemond B. J.)
• Zwaginga Jaap J., van der Holt Bronno, te Boekhorst Peter A., Biemond Bart J., Levin Mark-David, van der Griend René, Brand Anneke, Zweegman Sonja, Pruijt Hans F. M., Novotny Vera M. J., Vreugdenhil Art, de Groot Marco R., de Weerdt Okke, van Pampus Elisabeth C. M., van Maanen-Lamme Tanja M., Wittebol Shulamiet, Schipperus Martin R., Silbermann Matthijs H., Huijgens Peter C., Luten Marleen, Hollestein Rene, Brakenhoff Jan A. C., Schrama Jolanda G., Valster Fransje A. A., Velders Gerjo A., Koene Harry R. Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients Haematologica 2015;100 (3):e90-e92 [PubMed]
• Schimmel Marein, van Beers Eduard J., van Tuijn Charlotte F. J., Nur Erfan, Rijneveld Anita W., Mac Gillavry Melvin R., Brandjes Dees P. B., Schnog John-John B., Biemond Bart J. N-terminal pro-B-type natriuretic peptide, tricuspid jet flow velocity, and death in adults with sickle cell disease American journal of hematology 2015;90 (4):E75-E76 [PubMed]
• Versluis Jurjen, Hazenberg Carin L. E., Passweg Jakob R., van Putten Wim L. J., Maertens Johan, Biemond Bart J., Theobald Matthias, Graux Carlos, Kuball Jurgen, Schouten Harry C., Pabst Thomas, Löwenberg Bob, Ossenkoppele Gert, Vellenga Edo, Cornelissen Jan J., Meulendijks Ine, Cornelisse Petra, van Hooije Christel, Biaggi Christine, van der Holt Bronno, Labopin Myriam, de Bock B., Breems D. A., Zachee P., Ferrant A., Vekemans M. C., Mineur P., Delannoy A., Maertens J., Verhoef G., van Steenweghen S., Bosly A., Graux C., Jaeger E., Theobald M., Beck J., Fischer Th, Gjertsen B. T., Bargetzi M., Wernli M., Passweg J., Gratwohl A., Leoncini-Francini L., Marini G., Fey M. F., Pabst T., Chapuis B., Chalandon Y., Herr A., Wuillemin W. A. Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis Lancet. Haematology 2015;2 (10):e427-e436 [PubMed]
• Wessel H., Wiersinga W. J., Biemond B. J., Goorhuis A., Baars P. A., Krediet C. T. P. The best fit: do not discard AL amyloidosis too easily Acta clinica Belgica 2015;70 (1):73-75 [PubMed]

2014

• van Beers Eduard J., van der Plas Mart N., Nur Erfan, Bogaard Harm-Jan, van Steenwijk Reindert P., Biemond Bart J., Bresser Paul Exercise tolerance, lung function abnormalities, anemia, and cardiothoracic ratio in sickle cell patients American journal of hematology 2014;89 (8):819-824 [PubMed]
• Dieleman E. M. T. , Oldenburger F. , Biemond B. J. , Stalpers Lukas Het syndroom van Bing-Neel bij de ziekte van Waldenstrom Nederlands tijdschrift voor oncologie 2014;11 (5):196-201

2013

• Tonino S. H., Nur E., Otten H. M., Wykrzykowska J. J., Hoekstra J. B. L., Biemond B. J. Chest pain in sickle cell disease Netherlands journal of medicine 2013;71 (5):265-269 [PubMed]
• Jansen Rogier R., Biemond Bart J., Schinkel Janke, Koekkoek Sylvie M., Molenkamp Richard, de Jong Menno D., Visser Caroline E. Febrile neutropenia: significance of elaborated screening for respiratory viruses, and the comparison of different sampling methods, in neutropenic patients with hematological malignancies Virology journal 2013;10 (1):212 [PubMed]
• Terwijn Monique, van Putten Wim L. J., Kelder Angèle, van der Velden Vincent H. J., Brooimans Rik A., Pabst Thomas, Maertens Johan, Boeckx Nancy, de Greef Georgine E., Valk Peter J. M., Preijers Frank W. M. B., Huijgens Peter C., Dräger Angelika M., Schanz Urs, Jongen-Lavrecic Mojca, Biemond Bart J., Passweg Jakob R., van Gelder Michel, Wijermans Pierre, Graux Carlos, Bargetzi Mario, Legdeur Marie-Cecile, Kuball Jurgen, de Weerdt Okke, Chalandon Yves, Hess Urs, Verdonck Leo F., Gratama Jan W., Oussoren Yvonne J. M., Scholten Willemijn J., Slomp Jennita, Snel Alexander N., Vekemans Marie-Christiane, Löwenberg Bob, Ossenkoppele Gert J., Schuurhuis Gerrit J. High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study Journal of clinical oncology 2013;31 (31):3889-+ [PubMed]
• Thielen Noortje, van der Holt Bronno, Cornelissen Jan J., Verhoef Gregor E. G., Gussinklo Titia, Biemond Bart J., Daenen Simon M. G., Deenik Wendy, van Marwijk Kooy Rien, Petersen Eefke, Smit Willem M., Valk Peter J. M., Ossenkoppele Gert J., Janssen Jeroen J. W. M. Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: A randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON) European journal of cancer (Oxford, England 2013;49 (15):3242-3246 [PubMed]
• van der Land Veronica, Peters Marjolein, Biemond Bart J., Heijboer Harriët, Harteveld Cornelis L., Fijnvandraat Karin Markers of endothelial dysfunction differ between subphenotypes in children with sickle cell disease Thrombosis research 2013;132 (6):712-717 [PubMed]
• Schimmel Marein, Nur Erfan, Biemond Bart J., van Mierlo Gerard J., Solati Shabnam, Brandjes Dees P., Otten Hans-Martin, Schnog John-John, Zeerleder Sacha Nucleosomes and neutrophil activation in sickle cell disease painful crisis Haematologica 2013;98 (11):1797-1803 [PubMed]
• Saleh Mansoor N., Bussel James B., Cheng Gregory, Meyer Oliver, Bailey Christine K., Arning Michael, Brainsky Andres, Chong B., Pidcock M., Pabinger-Fasching I., Olney H., Arnold D., Assouline S., Shen Z., Yang R., Sun A., Mayer J., Pohlreichova V., Hlusi A., Marcher C., Nousiainen T., Godeau B., Cheze S., Viallard J., Ganser A., Matzdorff A., Salama A., Schroeder D., von Depka Prondzinski M., Hiller E., Rummel M., Anagnostopoulos A., Poziopoulos C., Wong R., Fabris F., Ciceri F., Angelini F., Vianelli N., Kim B., Novotný V., Biemond B. J., Schipperus M. R., Wittebol S., Blacklock H., Simpson D., Ganly P., Doocey R., Shamsi T., Aziz Z., Murillo S. Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study Blood 2013;121 (3):537-545 [PubMed]
• Yürük Koray, Milstein Dan M. J., Bezemer Rick, Bartels Sebastiaan A., Biemond Bart J., Ince Can Transfusion of banked red blood cells and the effects on hemorrheology and microvascular hemodynamics in anemic hematology outpatients Transfusion 2013;53 (6):1346-1352 [PubMed]
• Lauw Mandy N., van der Holt Bronno, Middeldorp Saskia, Meijers Joost C. M., Cornelissen Jan J., Biemond Bart J. Venous thromboembolism in adults treated for acute lymphoblastic leukaemia: Effect of fresh frozen plasma supplementation Thrombosis and haemostasis 2013;109 (4):633-642 [PubMed]

2012

• Ossenkoppele Gert J., Stussi Georg, Maertens Johan, van Montfort Kees, Biemond Bart J., Breems Dimitri, Ferrant August, Graux Carlos, de Greef Georgine E., Halkes C. J. M., Hoogendoorn Mels, Hollestein Rene M., Jongen-Lavrencic Mojca, Levin Mark D., van de Loosdrecht Arjan A., van Marwijk Kooij Marinus, van Norden Yvette, Pabst Thomas, Schouten Harry C., Vellenga Edo, Verhoef Gregor E. G., de Weerdt Okke, Wijermans Pierre, Passweg Jakob R., Löwenberg Bob Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK) Blood 2012;120 (24):4706-4711 [PubMed]
• van der Laan Anja M., Hirsch Alexander, Robbers Lourens F. H. J., Nijveldt Robin, Lommerse Ingrid, Delewi Ronak, van der Vleuten Pieter A., Biemond Bart J., Zwaginga Jaap Jan, van der Giessen Wim J., Zijlstra Felix, van Rossum Albert C., Voermans Carlijn, van der Schoot C. Ellen, Piek Jan J. A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: Monocytes and myocardial infarction American heart journal 2012;163 (1):57-65 [PubMed]
• Metske Hennie A., Postema Pieter G., Biemond Bart J., Bouman Catherine S. C. Cooling the crisis: Therapeutic hypothermia after sickle cardiac arrest Critical care medicine 2012;40 (2):651-653 [PubMed]
• Lammers A. J. Jolanda, de Porto Alexander P. N. A., Bennink Roelof J., van Leeuwen Ester M. M., Biemond Bart J., Goslings J. Carel, van Marle Jan, ten Berge Ineke J. M., Speelman Peter, Hoekstra Joost B. L. Hyposplenism: Comparison of different methods for determining splenic function American journal of hematology 2012;87 (5):484-489 [PubMed]
• Daenen S., van der Holt B., Dekker A. W., Willemze R., Rijneveld A. W., Biemond B. J., Muus P., van de Loosdrecht A. A., Schouten H. C., van Marwijk Kooy M., Breems D. A., Demuynck H., Maertens J., Wijermans P. W., Wittebol S., de Klerk E. W., Cornelissen J. J. Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON Leukemia 2012;26 (7):1726-1729 [PubMed]
• Nur Erfan, Brandjes Dees P., Teerlink Tom, Otten Hans-Martin, Oude Elferink Ronald P. J., Muskiet Frits, Evers Ludo M., ten Cate Hugo, Biemond Bart J., Duits Ashley J., Schnog John-John B. N-acetylcysteine reduces oxidative stress in sickle cell patients Annals of hematology 2012;91 (7):1097-1105 [PubMed]
• Yuruk Koray, Bartels Sebastiaan A., Milstein Dan M. J., Bezemer Rick, Biemond Bart J., Ince Can Red blood cell transfusions and tissue oxygenation in anemic hematology outpatients Transfusion 2012;52 (3):641-646 [PubMed]
• Lauw Mandy N., Bus Erik W. N., van Wulfften Palthe Alexander F. Y., Coppens Michiel, Homburg Christa H., Middeldorp Saskia, van der Schoot C. Ellen, Koene Harry R., Biemond Bart J. Relevance of the JAK2V617F mutation in patients with deep vein thrombosis of the leg Annals of hematology 2012;91 (1):103-107 [PubMed]

2011

• Vellenga Edo, van Putten Wim, Ossenkoppele Gert J., Verdonck Leo F., Theobald Matthias, Cornelissen Jan J., Huijgens Peter C., Maertens Johan, Gratwohl Alois, Schaafsma Ron, Schanz Urs, Graux Carlos, Schouten Harry C., Ferrant Augustin, Bargetzi Mario, Fey Martin F., Löwenberg Bob, Ferrant A., Delannoy A., Maertens J., Verhoef G., Bosly A., Graux C., Breems D. A., Zachee P., Mineur P., Jaeger E., Theobald M., Beck J., Fischer Th, Bargetzi M., Wernli M., Gratwohl A., Fey M. F., Pabst T., Chapuis B., Chalandon Y., Herr A., Wuillemin W. A., Gregor M., Jacky E., Schanz U., Leoncini-Francini L., Marini G., Piquet D., Zimmerli-Schwab B., Hess U., Binder D., Kroner Th, Biemond B. J. Autologous peripheral blood stem cell transplantation for acute myeloid leukemia Blood 2011;118 (23):6037-6042 [PubMed]
• Hazenberg M. D., Biemond B. J., Pals S. T., Zumpolle C. M., Schinkel C. J., Linthorst G. E., Hoekstra J. B. L., Vos J. M. I. Clinical pathological conference: a non-Hodgkin's lymphoma patient with persistent anaemia after chemotherapy Netherlands journal of medicine 2011;69 (10):469-473 [PubMed]
• Löwenberg Bob, Pabst Thomas, Vellenga Edo, van Putten Wim, Schouten Harry C., Graux Carlos, Ferrant Augustin, Sonneveld Pieter, Biemond Bart J., Gratwohl Alois, de Greef Georgine E., Verdonck Leo F., Schaafsma Martijn R., Gregor Michael, Theobald Matthias, Schanz Urs, Maertens Johan, Ossenkoppele Gert J., Ferrant A., Delannoy A., Mineur P., Maertens J., Verhoef G., Demuynck H., Bosly A., Graux C., Breems D. A., Zachee P., Jaeger E., Theobald M., Beck J., Fischer Th, Bargetzi M., Wernli M., Gratwohl A., Heim D., Fey M. F., Pabst T., Chapuis B., Herr A., Wuillemin W. A., Gregor M., Jacky E., Schans U., Wittebol S., van der Lelie J., de Valk B., Ossenkoppele G. J., Huijgens P. C., Wijermans P. W. Cytarabine dose for acute myeloid leukemia New England journal of medicine 2011;364 (11):1027-1036 [PubMed]
• Nur Erfan, Verwijs Mirjam, de Waart Dirk R., Schnog John-John B., Otten Hans-Martin, Brandjes Dees P., Biemond Bart J., Elferink Ronald P. J. Oude Increased efflux of oxidized glutathione (GSSG) causes glutathione depletion and potentially diminishes antioxidant defense in sickle erythrocytes BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 2011;1812 (11):1412-1417 [PubMed]
• Rijneveld A. W., van der Holt B., Daenen S. M. G. J., Biemond B. J., de Weerdt O., Muus P., Maertens J., Mattijssen V., Demuynck H., Legdeur M. C. J. C., Wijermans P. W., Wittebol S., Spoelstra F. M., Dekker A. W., Ossenkoppele G. J., Willemze R., Cornelissen J. J. Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40 Leukemia 2011;25 (11):1697-1703 [PubMed]
• Hirsch Alexander, Nijveldt Robin, van der Vleuten Pieter A., Tijssen Jan G. P., van der Giessen Willem J., Tio René A., Waltenberger Johannes, ten Berg Jurrien M., Doevendans Pieter A., Aengevaeren Wim R. M., Zwaginga Jaap Jan, Biemond Bart J., van Rossum Albert C., Piek Jan J., Zijlstra Felix Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial European heart journal 2011;32 (14):1736-1747 [PubMed]
• van der Plas Evelyn M., van den Tweel Xandra W., Geskus Ronald B., Heijboer Harriët, Biemond Bart J., Peters Marjolein, Fijnvandraat Karin Mortality and causes of death in children with sickle cell disease in the Netherlands, before the introduction of neonatal screening British journal of haematology 2011;155 (1):106-110 [PubMed]
• Nur Erfan, Biemond Bart J., Otten Hans-Martin, Brandjes Dees P., Schnog John-John B. Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management American journal of hematology 2011;86 (6):484-489 [PubMed]
• Nur Erfan, van Beers Eduard J., Martina Shuena, Cuccovillo Ivan, Otten Hans-Martin, Schnog John-John B., Meijers Joost C. M., Mantovani Alberto, Brandjes Dees P., Bottazzi Barbara, Biemond Bart J. Plasma levels of pentraxin-3, an acute phase protein, are increased during sickle cell painful crisis Blood cells, molecules & diseases 2011;46 (3):189-194 [PubMed]
• van der Helm Lieke H., Alhan Canan, Wijermans Pierre W., van Marwijk Kooy Marinus, Schaafsma Ron, Biemond Bart J., Beeker Aart, Hoogendoorn Mels, van Rees Bastiaan P., de Weerdt Okke, Wegman Jurgen, Libourel Ward J., Luykx-de Bakker Sylvia A., Minnema Monique C., Brouwer Rolf E., Croon-de Boer Fransien, Eefting Matthijs, Jie Kon-Siong G., van de Loosdrecht Arjan A., Koedam Jan, Veeger Nic J. G. M., Vellenga Edo, Huls Gerwin Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme British journal of haematology 2011;155 (5):599-606 [PubMed]
• van der Laan Anja M., Hirsch Alexander, Haeck Joost D. E., Nijveldt Robin, Delewi Ronak, Biemond Bart J., Tijssen Jan G. P., Marques Koen M. J., Zijlstra Felix, van Rossum Albert C., Piek Jan J. Recovery of microcirculation after intracoronary infusion of bone marrow mononuclear cells or peripheral blood mononuclear cells in patients treated by primary percutaneous coronary intervention the Doppler substudy of the Hebe trial JACC. Cardiovascular interventions 2011;4 (8):913-920 [PubMed]
• Nur Erfan Vasculopathy in sickle cell disease 2011. 211p. ISBN 9789090260877. [UvA Dissertations Online] University of Amsterdam. (Supervisor: van Oers M. H. J.; Co-supervisors: Biemond B. J., Brandjes D. P. M.)

2010

• van Tuijn Charlotte F. J., Nur Erfan, van Beers Eduard J., Zaaijer Hans L., Biemond Bart J. Acute chest syndrome in sickle cell disease due to the new influenza A (H1N1) virus infection American journal of hematology 2010;85 (4):303-304 [PubMed]
• Biemond B. J. Endoscopic ultrasonography and pancreatic cancer - close companions Netherlands journal of medicine 2010;68 (9):341-342 [PubMed]
• Löwenberg Bob, Beck Joachim, Graux Carlos, van Putten Wim, Schouten Harry C., Verdonck Leo F., Ferrant Augustin, Sonneveld Pieter, Jongen-Lavrencic Mojca, von Lilienfeld-Toal Marie, Biemond Bart J., Vellenga Edo, Breems Dimitri, de Muijnck Hilde, Schaafsma Ron, Verhoef Gregor, Döhner Hartmut, Gratwohl Alois, Pabst Thomas, Ossenkoppele Gert J., Maertens Johan, Ferrant A., Delannoy A., Maertens J., Verhoef G., Demuynck H., Bosly A., Graux C., Breems D. A., Zachee P., Jaeger E., Beck J., Fischer Th, Glasmacher A., Hartmann F., Grimminger W., Döhner H., Bargetzi M., Wernli M., Gratwohl A., Fey M. F., Pabst T., Passweg J., Chalandon Y., Herr A., Wuillemin W. A., Stuessi G., Schanz U., van der Lelie J., de Valk B. Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study Blood 2010;115 (13):2586-2591 [PubMed]
• van Beers Eduard J., Biemond Bart J., Schnog John-John B. Letter in response to: "Pulmonary thrombi are not detected by 3D magnetic resonance angiography in adults with sickle cell anemia and an elevated triscuspid regurgitant jet velocity" American journal of hematology 2010;85 (3):217 [PubMed]
• Van der Plas E. M., van den Tweel X. W., Heijboer H., Geskus R. B., Biemond B. J., Peters M., Fijnvandraat K. Mortality and causes of death in children with sickle cell disease in the Netherlands, before the introduction of neonatal screening. Pediatric clinics Amsterdam 2010;21 (1):5-6
• van Tuijn Charlotte F. J., van Beers Eduard J., Schnog John-John B., Biemond Bart J. Pain rate and social circumstances rather than cumulative organ damage determine the quality of life in adults with sickle cell disease American journal of hematology 2010;85 (7):532-535 [PubMed]
• Landburg P. P., Teerlink T., Biemond B. J., Brandjes D. P. M., Muskiet F. A. J., Duits A. J., Schnog J. B. Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype Blood cells, molecules & diseases 2010;44 (4):229-232 [PubMed]
• Nur Erfan, Brandjes Dees P., Schnog John-John B., Otten Hans-Martin, Fijnvandraat Karin, Schalkwijk Casper G., Biemond Bart J. Plasma levels of advanced glycation end products are associated with haemolysis-related organ complications in sickle cell patients British journal of haematology 2010;151 (1):62-69 [PubMed]
• Kaandorp S. P., Lauw M. N., van der Schoot C. E., Goddijn M., van der Veen F., Koene H. R., Biemond B. J., Middeldorp S. Prevalence of JAK2V617F mutation in women with unexplained recurrent miscarriage Journal of thrombosis and haemostasis 2010;8 (12):2837-2839 [PubMed]
• Biemond B. J. Treatment considerations for primary myelofibrosis Netherlands journal of medicine 2010;68 (1):291-292 [PubMed]
• Nur Erfan, Mairuhu Willem, Biemond Bart J., van Zanten Anton P., Schnog John-John B., Brandjes Dees P., Otten Hans-Martin Urinary markers of bone resorption, pyridinoline and deoxypyridinoline, are increased in sickle cell patients with further increments during painful crisis American journal of hematology 2010;85 (11):902-904 [PubMed]
• Milstein Dan M. J., te Boome Liane C. J., Cheung Yuk Wah, Lindeboom Jérôme A. H., van den Akker Hans P., Biemond Bart J., Ince Can Use of sidestream dark-field (SDF) imaging for assessing the effects of high-dose melphalan and autologous stem cell transplantation on oral mucosal microcirculation in myeloma patients Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2010;109 (1):91-97 [PubMed]

2009

• Nur Erfan, Kim Yu-Sok, Truijen Jasper, van Beers Eduard J., Davis Shyrin C. A. T., Brandjes Dees P., Biemond Bart J., van Lieshout Johannes J. Cerebrovascular reserve capacity is impaired in patients with sickle cell disease Blood 2009;114 (16):3473-3478 [PubMed]
• Strijbos Michiel H., Landburg Precious P., Nur Erfan, Teerlink Tom, Leebeek Frank W. G., Rijneveld Anita W., Biemond Bart J., Sleijfer Stefan, Gratama Jan W., Duits Ashley J., Schnog John-John B. Circulating endothelial cells: a potential parameter of organ damage in sickle cell anemia? Blood cells, molecules & diseases 2009;43 (1):63-67 [PubMed]
• van Beers Eduard J., Schaap Marianne C. L., Berckmans René J., Nieuwland Rienk, Sturk Augueste, van Doormaal Frederiek F., Meijers Joost C. M., Biemond Bart J. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease Haematologica 2009;94 (11):1513-1519 [PubMed]
• de Heer K., Visser C. E., Biemond B. J., Blijlevens N. M. A. De plaats van primaire antimycotische profylaxe bij intensieve chemotherapie en allogene stamceltransplantatie Nederlands tijdschrift voor hematologie 2009;6 (7):268-275
• Kim Yu-Sok, Nur Erfan, van Beers Eduard J., Truijen Jasper, Davis Shyrin C. A. T., Biemond Bart J., van Lieshout Johannes J. Dynamic Cerebral Autoregulation in Homozygous Sickle Cell Disease Stroke; a journal of cerebral circulation 2009;40 (3):808-814 [PubMed]
• Landburg P. P., Nur E., Maria N., Brandjes D. P. M., Biemond B. J., Schnog J. B., Duits A. J. Elevated circulating stromal-derived factor-1 levels in sickle cell disease Acta haematologica 2009;122 (1):64-69 [PubMed]
• van Beem Rachel T., Nur Erfan, Zwaginga Jaap Jan, Landburg Precious P., van Beers Eduard J., Duits Ashley J., Brandjes Dees P., Lommerse Ingrid, de Boer Hetty C., van der Schoot C. Ellen, Schnog John-John B., Biemond Bart J. Elevated endothelial progenitor cells during painful sickle cell crisis Experimental hematology 2009;37 (9):1054-1059 [PubMed]
• Löwenberg Bob, Ossenkoppele Gert J., van Putten Wim, Schouten Harry C., Graux Carlos, Ferrant Augustin, Sonneveld Pieter, Maertens Johan, Jongen-Lavrencic Mojca, von Lilienfeld-Toal Marie, Biemond Bart J., Vellenga Edo, van Marwijk Kooy Marinus, Verdonck Leo F., Beck Joachim, Döhner Hartmut, Gratwohl Alois, Pabst Thomas, Verhoef Gregor, Ferrant A., Delannoy A., Maertens J., Verhoef G., Demuynck H., Bosly A., Graux C., Breems D. A., Zachee P., Jaeger E., Beck J., Fischer T., von Lilienfeld-Toal M., Glasmacher A., Salwender H. J., Hartmann F., Goetze K., Grimminger W., Döhner H., Bargetzi M., Wernli M., Gratwohl A., Fey M. F., Pabst T., Chapuis B., Herr A., Wuillemin W. A., Jacky E., Schans U., Wittebol S., van der Lelie J. High-dose daunorubicin in older patients with acute myeloid leukemia New England journal of medicine 2009;361 (13):1235-1248 [PubMed]
• Biemond B. J., Kerkhoffs J. L. H. Indicaties voor bloedtransfusie bij sikkelcelziekte Tijdschrift voor bloedtransfusie 2009;2 (4):118-124
• van Beers Eduard, Schnog John-John, Biemond Bart Lung function tests in patients with sickle cell disease: A reply American journal of hematology 2009;84 (5):310-311 [PubMed]
• Kerkhoffs J. L. H., Smiers F. J., Biemond B. J. Overwegingen en dilemma's rond allogene stamceltransplantatie voor sikkelcelziekte Nederlands tijdschrift voor hematologie 2009;6 (5):173-181
• Biemond B. J. Preventie en behandeling van sikkelcelziektegerelateerde complicaties Nederlands tijdschrift voor hematologie 2009;6 (2):56-61
• Takkenberg R. B., Zaaijer Hans L., ten Cate David F., Biemond Bart J., Jansen Peter L. M., Reesink Henk W. Reactivatie van het hepatitis B-virus bij patiënten met een hematologische maligniteit Nederlands tijdschrift voor geneeskunde 2009;153 (19):926-931 [PubMed]
• Kroot Joyce J. C., Laarakkers Coby M. M., Kemna Erwin H. J. M., Biemond Bart J., Swinkels Dorine W. Regulation of serum hepcidin levels in sickle cell disease Haematologica 2009;94 (6):885-887 [PubMed]

2008

• Landburg Precious P., Teerlink Tom, van Beers Eduard J., Muskiet Frits A. J., Kappers-Klunne Mies C., van Esser Joost W. J., Mac Gillavry Melvin R., Biemond Bart J., Brandjes Dees P. M., Duits Ashley J., Schnog John-John Association of asymmetric dimethylarginine with sickle cell disease-related pulmonary hypertension Haematologica 2008;93 (9):1410-1412 [PubMed]
• van der Laan A., Hirsch A., Nijveldt R., van der Vleuten P. A., van der Giessen W. J., Doevendans P. A., Waltenberger J., ten Berg J. M., Aengevaeren W. R. M., Zwaginga J. J., Biemond B. J., van Rossum A. C., Tijssen J. G. P., Zijlstra F., Piek J. J. Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results Netherlands heart journal 2008;16 (12):436-439 [PubMed]
• van Beers Eduard J., Nur Erfan, Schaefer-Prokop Cornelia M., Mac Gillavry Melvin R., van Esser Joost W. J., Brandjes Dees P. M., Kappers-Klunne Maria C., Duits Ashley J., Muskiet Frits A. J., Schnog John-John B., Biemond Bart J. Cardiopulmonary imaging, functional and laboratory studies in sickle cell disease associated pulmonary hypertension American journal of hematology 2008;83 (11):850-854 [PubMed]
• Biemond B. J., Giordano P. C. Hemoglobinopathieën: abnormale hemoglobines en thalassemieën - hoofdstuk 6in: Bob Löwenberg, Gert J. Ossenkoppele, editors. Handboek Hematologie. Utrecht: De Tijdstroom; 2008. p. 65-80, ISBN 9789058981325
• Hirsch Alexander, Nijveldt Robin, van der Vleuten Pieter A., Tio René A., van der Giessen Willem J., Marques Koen M. J., Doevendans Pieter A., Waltenberger Johannes, ten Berg Jurrien M., Aengevaeren Wim R. M., Biemond Bart J., Tijssen Jan G. P., van Rossum Albert C., Piek Jan J., Zijlstra Felix Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: Pilot study of the multicenter HEBE trial Catheterization and cardiovascular interventions 2008;71 (3):273-281 [PubMed]
• van Beers Eduard J., van Eck-Smit Berthe L. F., Mac Gillavry Melvin R., van Tuijn Charlotte F. J., van Esser Joost W. J., Brandjes Dees P. M., Kappers-Klunne Mies C., Duits Ashley J., Biemond Bart J., Schnog John-John B. Large and medium-sized pulmonary artery obstruction does not play a role of primary importance in the etiology of sickle-cell disease-associated pulmonary hypertension Chest 2008;133 (3):646-652 [PubMed]
• van Beers E. J., Spronk H. M. H., ten Cate H., Duits A. J., Brandjes D. P. M., van Esser J. W. J., Biemond B. J., Schnog J. B. No association of the hypercoagulable state with sickle cell disease related pulmonary hypertension Haematologica 2008;93 (5):e42-e44 [PubMed]
• van Beers Eduard J., Goedhart Peter T., Unger Michiel, Biemond Bart J., Ince Can Normal sublingual microcirculation during painful crisis in sickle cell disease Microvascular research 2008;76 (1):57-60 [PubMed]
• van Beem Rachel T., Hirsch Alexander, Lommerse Ingrid M., Zwaginga Jaap Jan, Noort Willy A., Biemond Bart J., Piek Jan J., van der Schoot C. Ellen, Voermans Carlijn Recovery and functional activity of mononuclear bone marrow and peripheral blood cells after different cell isolation protocols used in clinical trials for cell therapy after acute myocardial infarction EuroIntervention 2008;4 (1):133-138 [PubMed]
• van Beers Eduard J. Sickle cell disease, pathophysiology and clinical complications. 2008. 187p. ISBN 9789090233994. [UvA Dissertations Online] University of Amsterdam. (Supervisor: van Oers M. H. J.; Co-supervisors: Biemond B. J., Schnog J. B.)
• van Beers Eduard J., van Tuijn Charlotte F. J., Mac Gillavry Melvin R., van der Giessen Anna, Schnog John-John B., Biemond Bart J. Sickle cell disease-related organ damage occurs irrespective of pain rate: implications for clinical practice Haematologica 2008;93 (5):757-760 [PubMed]
• van Beers Edward J., Nieuwdorp Max, Duits Ashley J., Evers Ludo M., Schnog John-John B., Biemond Bart J. Sickle cell patients are characterized by a reduced glycocalyx volume Haematologica 2008;93 (2):307-308 [PubMed]

2007

• van Beers Eduard J., van Tuijn Charlotte F. J., Nieuwkerk Pythia T., Friederich Philip W., Vranken Jan H., Biemond Bart J. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial American journal of hematology 2007;82 (11):955-960 [PubMed]
• Biemond Bart J., Perzborn Elisabeth, Friederich Philip W., Levi Marcel, Buetehorn Ulf, Buller Harry R. Prevention and treatment of experimental thrombosis in rabbits with rivaroxaban (BAY 597939) - an oral, direct factor Xa inhibitor Thrombosis and haemostasis 2007;97 (3):471-477 [PubMed]
• Niers T. M. H., Di Nisio M., Klerk C. P. W., Baarslag H. J., Bueller H. R., Biemond B. J. Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study Journal of thrombosis and haemostasis 2007;5 (9):1878-1882 [PubMed]
• de Heer K., Silbermann M. H., Koene H. R., Biemond B. J., Muller H. P., van Oers M. H. J. Systematische diagnostiek van erytrocytose Nederlands tijdschrift voor geneeskunde 2007;151 (32):1770-1776 [PubMed]
• Klein Saskia K., Biemond Bart J., van Oers Marinus H. J. Two cases of isolated symptomatic myocarditis induced by all-trans retinoic acid (ATRA) Annals of hematology 2007;86 (12):917-918 [PubMed]
• Koene H. R., Biemond B. J., van der Schoot C. E. Van gen naar ziekte; JAK2 en polycythaemia vera Nederlands tijdschrift voor geneeskunde 2007;151 (32):1784-1787 [PubMed]

2006

• Hirsch Alexander, Nijveldt Robin, van der Vleuten Pieter A., Biemond Bart J., Doevendans Pieter A., van Rossum Albert C., Tijssen Jan G., Zijlstra Felix, Piek Jan J. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial American heart journal 2006;152 (3):434-441 [PubMed]

2005

• van Beers E. J., Peters M., Biemond B. J. Pathofysiologie en behandeling van sikkelcelziekte Nederlands tijdschrift voor geneeskunde 2005;149 (21):1144-1149 [PubMed]
• van Royen Niels, Schirmer Stephan H., Atasever Bektas, Behrens Casper Y. H., Ubbink Dirk, Buschmann Eva E., Voskuil Michiel, Bot Pieter, Hoefer Imo, Schlingemann Reinier O., Biemond Bart J., Tijssen J. G., Bode Christoph, Schaper Wolfgang, Oskam Jacques, Legemate Dink A., Piek Jan J., Buschmann Ivo START trial - A pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease Circulation 2005;112 (7):1040-1046 [PubMed]

2004

• ter Horst Simone A. J., Wagenaar Gerry T. M., de Boer Eveline, van Gastelen Margôt A., Meijers Joost C. M., Biemond Bart J., Poorthuis Ben J. H. M., Walther Frans J. Pentoxifylline reduces fibrin deposition and prolongs survival in neonatal hyperoxic lung injury Journal of applied physiology (Bethesda, Md. 2004;97 (5):2014-2019 [PubMed]

2000

• Friederich P. W., Keller T. T., Biemond B. J., Peters R. J., Hornberger W., Büller H. R., Levi M. [=Marcel M.] Successful attenuation of venous thrombus growth in rabbits after the administration of a novel oral thrombin inhibitor Thrombosis and haemostasis 2000;84 (5):858-864 [PubMed]

1999

• Levi M. [=Marcel M.], Friederich P. W., Middleton S., de Groot P. G., Wu Y. P., Harris R., Biemond B. J., Heijnen H. F., Levin J., ten Cate J. W. Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits Nature medicine 1999;5 (1):107-111 [PubMed]

1998

• Levi M. [=Marcel M.], van der Poll T., ten Cate H., Kuipers B., Biemond B. J., Jansen H. M., ten Cate J. W. Differential effects of anti-cytokine treatment on bronchoalveolar hemostasis in endotoxemic chimpanzees American journal of respiratory and critical care medicine 1998;158 (1):92-98 [PubMed]
• Minnema M. C., Friederich P. W., Levi M. [=Marcel M.], von dem Borne P. A., Mosnier L. O., Meijers J. C., Biemond B. J., Hack C. E., Bouma B. N., ten Cate H. Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor Journal of clinical investigation 1998;101 (1):10-14 [PubMed]

1997

• Biemond B. J., Friederich P. W., Koschinsky M. L., Levi M. [=Marcel M.], Sangrar W., Xia J., Büller H. R., ten Cate J. W. Apolipoprotein(a) attenuates endogenous fibrinolysis in the rabbit jugular vein thrombosis model in vivo Circulation 1997;96 (5):1612-1615 [PubMed]
• Friederich P. W., Levi M. [=Marcel M.], Biemond B. J., Charlton P., Templeton D., van Zonneveld A. J., Bevan P., Pannekoek H., ten Cate J. W. Novel low-molecular-weight inhibitor of PAI-1 (XR5118) promotes endogenous fibrinolysis and reduces postthrombolysis thrombus growth in rabbits Circulation 1997;96 (3):916-921 [PubMed]

1996

• Biemond B. J., Friederich P. W., Levi M. [=Marcel M.], Vlasuk G. P., Büller H. R., ten Cate J. W. Comparison of sustained antithrombotic effects of inhibitors of thrombin and factor Xa in experimental thrombosis Circulation 1996;93 (1):153-160 [PubMed]
• ten Cate H., Biemond B. J., Levi M. [=Marcel M.], Wuillemin W. A., Bauer K. A., Barzegar S., Buller H. R., Hack C. E., ten Cate J. W., Rosenberg R. D. Factor XIa induced activation of the intrinsic cascade in vivo Thrombosis and haemostasis 1996;75 (3):445-449 [PubMed]
• Wuillemin W. A., Hack C. E., Bleeker W. K., Biemond B. J., Levi M. [=Marcel M.], ten Cate H. Inactivation of factor Xia in vivo: studies in chimpanzees and in humans Thrombosis and haemostasis 1996;76 (4):549-555 [PubMed]

1995

• Biemond B. J., Levi M. [=Marcel M.], ten Cate H., Soule H. R., Morris L. D., Foster D. L., Bogowitz C. A., van der Poll T., Büller H. R., ten Cate J. W. Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa Thrombosis and haemostasis 1995;73 (2):223-230 [PubMed]
• van der Poll T., Levi M. [=Marcel M.], ten Cate H., Jansen J., Biemond B. J., Haagmans B. L., Eerenberg A., van Deventer S. J., Hack C. E., ten Cate J. W. Effect of postponed treatment with an anti-tumour necrosis factor (TNF) F(ab')2 fragment on endotoxin-induced cytokine and neutrophil responses in chimpanzees Clinical and experimental immunology 1995;100 (1):21-25 [PubMed]
• Biemond B. J., Levi M. [=Marcel M.], ten Cate H., van der Poll T., Büller H. R., Hack C. E., ten Cate J. W. Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades Clinical science (London, England 1995;88 (5):587-594 [PubMed]
• Biemond B. J., Levi M. [=Marcel M.], Coronel R., Janse M. J., ten Cate J. W., Pannekoek H. Thrombolysis and reocclusion in experimental jugular vein and coronary artery thrombosis. Effects of a plasminogen activator inhibitor type 1-neutralizing monoclonal antibody Circulation 1995;91 (4):1175-1181 [PubMed]

1994

• Biemond B. J., Levi M. [=Marcel M.], Nurmohamed M. T., Büller H. R., ten Cate J. W. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model Thrombosis and haemostasis 1994;72 (3):377-380 [PubMed]
• ten Cate H., Schenk B. E., Biemond B. J., Levi M. [=Marcel M.], van der Poll T., Buller H. R., ten Cate J. W. A review of studies of the activation of the blood coagulation mechanism in chimpanzees (Pan troglodytes) Journal of medical primatology 1994;23 (5):280-284 [PubMed]
• van der Poll T., Levi M. [=Marcel M.], van Deventer S. J., ten Cate H., Haagmans B. L., Biemond B. J., Büller H. R., Hack C. E., ten Cate J. W. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees Blood 1994;83 (2):446-451 [PubMed]
• ten Cate H., Levi M. [=Marcel M.], van der Poll T., Biemond B. J., van Deventer S. J., Buller H. R., ten Cate J. W. Inhibition of extrinsic coagulation activation in endotoxemia; therapeutic implications Progress in clinical and biological research 1994;388:215-219 [PubMed]

1992

• Levi M. [=Marcel M.], Biemond B. J., van Zonneveld A. J., ten Cate J. W., Pannekoek H. Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis Circulation 1992;85 (1):305-312 [PubMed]

1991

• Levi M. [=Marcel M.], Biemond B. J., Stuck A., ten Cate J. Wouter The effect of radiological contrast media in animal models of experimental thrombosis Seminars in hematology 1991;28 (4 Suppl 7):27-30; discussion 38-41 [PubMed]
• Levi M. [=Marcel M.], Biemond B. J., Sturk A., Hoek J., ten Cate J. W. Variable effects of radiological contrast media on thrombus growth in a rabbit jugular vein thrombosis model Thrombosis and haemostasis 1991;66 (2):218-221 [PubMed]